NO20004405L - Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati - Google Patents

Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati

Info

Publication number
NO20004405L
NO20004405L NO20004405A NO20004405A NO20004405L NO 20004405 L NO20004405 L NO 20004405L NO 20004405 A NO20004405 A NO 20004405A NO 20004405 A NO20004405 A NO 20004405A NO 20004405 L NO20004405 L NO 20004405L
Authority
NO
Norway
Prior art keywords
carbon atoms
prophylaxis
pharmaceutical composition
ocular
alkyl group
Prior art date
Application number
NO20004405A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004405D0 (no
Inventor
Mitsuyoshi Azuma
Yukuo Yoshida
Yuji Sakamoto
Jun Inoue
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of NO20004405D0 publication Critical patent/NO20004405D0/no
Publication of NO20004405L publication Critical patent/NO20004405L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20004405A 1998-03-05 2000-09-04 Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati NO20004405L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5362498 1998-03-05
PCT/JP1999/001031 WO1999044624A2 (en) 1998-03-05 1999-03-03 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy

Publications (2)

Publication Number Publication Date
NO20004405D0 NO20004405D0 (no) 2000-09-04
NO20004405L true NO20004405L (no) 2000-11-03

Family

ID=12948075

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004405A NO20004405L (no) 1998-03-05 2000-09-04 Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati

Country Status (17)

Country Link
US (1) US6423691B1 (de)
EP (2) EP1058553B1 (de)
JP (1) JP4422894B2 (de)
KR (1) KR20010041605A (de)
CN (1) CN1298304A (de)
AR (1) AR018576A1 (de)
AT (2) ATE400277T1 (de)
AU (1) AU2745599A (de)
BR (1) BR9908566A (de)
CA (1) CA2322854A1 (de)
DE (2) DE69939075D1 (de)
HU (1) HUP0101733A3 (de)
ID (1) ID27083A (de)
NO (1) NO20004405L (de)
PL (1) PL343412A1 (de)
WO (1) WO1999044624A2 (de)
ZA (1) ZA991749B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002034252A1 (ja) * 2000-10-26 2004-03-04 千寿製薬株式会社 ジペプチジルアルデヒド誘導体含有医薬組成物
DE60330038D1 (de) * 2002-07-22 2009-12-24 Senju Pharma Co Neue alpha-ketoamidderivate und deren verwendung
ATE453132T1 (de) 2002-09-19 2010-01-15 Koninkl Philips Electronics Nv Optischer schalter auf basis von elektrobenetzung
WO2004060373A1 (ja) * 2002-12-27 2004-07-22 Santen Pharmaceutical Co., Ltd. 滲出型加齢黄斑変性治療剤
RU2316295C1 (ru) * 2006-03-16 2008-02-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию Способ консервативного лечения гемангиомы придаточного аппарата глаза и орбиты у детей
PL3111926T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego
JPWO2011105070A1 (ja) 2010-02-25 2013-06-20 パナソニック株式会社 需給制御装置、需給制御方法、およびプログラム
RU2441631C2 (ru) * 2010-04-07 2012-02-10 Учреждение Российской академии медицинских наук Научно-исследовательский институт глазных болезней РАМН (НИИГБ РАМН) Способ поэтапного поступательного лазерного лечения ретиношизиса
US8697746B2 (en) 2010-07-14 2014-04-15 Senju Pharmaceutical Co., Ltd. Solid dispersion of alpha-ketoamide derivatives
RU2452436C1 (ru) * 2011-01-31 2012-06-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения атрофии зрительного нерва сосудистого генеза
KR102354410B1 (ko) * 2014-02-21 2022-01-21 다이니뽄 스미토모 세이야쿠 가부시키가이샤 눈 질환 치료제, 이의 스크리닝 방법, 및 망막 색소 상피 세포 이식과 연관된 거부 반응의 예측 방법
WO2017044743A1 (en) 2015-09-11 2017-03-16 The Schepens Eye Research Institute, Inc. Compositions and methods for prevention and treatment of corneal haze and scarring
US11439608B2 (en) 2017-09-25 2022-09-13 Qun Lu Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease
PL424452A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504938A3 (en) 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
JP2848232B2 (ja) * 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
JP3599287B2 (ja) 1993-04-28 2004-12-08 三菱化学株式会社 スルホンアミド誘導体
EP0731107A1 (de) 1995-02-13 1996-09-11 Takeda Chemical Industries, Ltd. Herstellung von Aldehyd-Derivaten
DE69625575T2 (de) * 1995-10-25 2003-09-25 Senju Pharmaceutical Co., Ltd. Angiogense-Inhibitor
DE69637307T2 (de) * 1995-11-28 2008-02-28 Cephalon, Inc. Aus d-aminosäuren abgeleitete cystein-und serinproteasehemmer
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung

Also Published As

Publication number Publication date
US6423691B1 (en) 2002-07-23
HUP0101733A2 (hu) 2001-11-28
HUP0101733A3 (en) 2001-12-28
DE69925578T2 (de) 2006-04-27
JP4422894B2 (ja) 2010-02-24
JP2002505297A (ja) 2002-02-19
EP1504760A1 (de) 2005-02-09
EP1058553A2 (de) 2000-12-13
WO1999044624A3 (en) 1999-10-21
CA2322854A1 (en) 1999-09-10
KR20010041605A (ko) 2001-05-25
CN1298304A (zh) 2001-06-06
WO1999044624A2 (en) 1999-09-10
DE69939075D1 (de) 2008-08-21
PL343412A1 (en) 2001-08-13
ID27083A (id) 2001-02-22
NO20004405D0 (no) 2000-09-04
AU2745599A (en) 1999-09-20
ZA991749B (en) 1999-09-16
ATE400277T1 (de) 2008-07-15
AR018576A1 (es) 2001-11-28
EP1058553B1 (de) 2005-06-01
BR9908566A (pt) 2000-11-21
DE69925578D1 (de) 2005-07-07
ATE296635T1 (de) 2005-06-15
EP1504760B1 (de) 2008-07-09

Similar Documents

Publication Publication Date Title
NO20004405L (no) Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati
DE69528005D1 (de) Prolineamid-Derivate
FI943948A0 (fi) Heterosykliset hiilihappojohdannaiset
DE60315674D1 (de) Neue imidazopyridine und ihre verwendung
BR0313407A (pt) Novo uso de derivados de benzotiazol
ATE319458T1 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
BR0015195A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de uma condição associada com a transmissão reduzida de nicotina para o tratamento ou profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e para o tratamento ou profilaxia de doenças ou condições humanas
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
HUP0201284A2 (hu) Hatóanyagként kinazolindionszármazék kimáz inhibitort tartalmazó gyógyászati készítmények fibrózis megelőzésére vagy kezelésére
NO20054855L (no) Preventiv/hjelpemiddel for retinal nervesykdommer inneholdende alkyleterderivater eller salter derav
NZ516100A (en) Streptogramin derivatives, preparation and compositions containing them
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
BR9910637A (pt) Composto da série da benzofuroxana usada para distúrbios cardiovasculares, processos para a preparação dos derivados de benzofuroxana, e para a preparação de 5 (6)-[(2,3-diidróxi propilóxi)-carbonil] benzofuroxana, uso do composto, composição farmacêutica, processo para a preparação da mesma, e, processo para o tratamento de um mamìfero, incluindo um ser humano, de doença cardìacas da coronária.
ATE284684T1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
CA2202904A1 (en) Pharmaceutical composition for prophylaxis and treatment of type i allergic diseases
UA41329C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, похідні 3-фенілсульфоніл-3,7-діазабіцикло[3,3,1]нонану та лікарський засіб для лікування аритмії
DE69518706D1 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
IS8096A (is) Notkun karbamasepínafleiða til að meðhöndla órósemi í sjúklingum er þjást af vitglöpum
DE69713648D1 (de) Benzopyranderivate und ihre Verwendung zur Behandlung von Herzkrankheiten
NO894325L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO20004679L (no) Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse
AU6042486A (en) 1,4-benzodioxane derivatives
AU2013888A (en) Uricosuric composition
GB2011887A (en) Antiallergic agent

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application